Cytori Therapeutics Inc (CYTX) Drops 6.45% on January 12

Equities Staff |

Cytori Therapeutics Inc (CYTX) was one of the Russell 2000's biggest losers for Tuesday January 12 as the stock slid 6.45% to $0.16, a loss of $-0.0109 per share. Starting at an opening price of $0.18 a share, the stock traded between $0.16 and $0.18 over the course of the trading day. Volume was 1.62 million shares over 1,457 trades, against an average daily volume of 1.66 million shares and a total float of 158.49 million.

The losses send Cytori Therapeutics Inc down to a market cap of $25.06 million. In the last year, Cytori Therapeutics Inc has traded between $1.47 and $0.16, and its 50-day SMA is currently $0.30 and 200-day SMA is $0.52.

Cytori Therapeutics Inc is engaged in the development of novel treatments for cardiovascular disease and soft tissue injuries and burns.

Cytori Therapeutics Inc is based out of San Diego, CA and has some 78 employees. Its CEO is Marc H. Hedrick.

For a complete fundamental analysis analysis of Cytori Therapeutics Inc, check out Equities.com’s Stock Valuation Analysis report for CYTX. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

VOIP PAL.COM INC

VOIP-PAL COM Inc is a development stage company. The Company is engaged in broadband Voice-over-Internet Protocol ("VoIP") market with the ownership and continuing development of a portfolio of VoIP Patents.

Private Markets

GoCoin

Blockchain currencies (e.g. Bitcoin) provide a new disruptive way to transfer value between parties over the internet as opposed to going through banks. GoCoin provides online merchants with a suite…

Knightscope

Autonomous security robots providing advanced detection capabilities at $7 per hour - aiming to define the future of security. Help #StopTheViolence.